InfoMedics, Inc. Reports Progress in Patient Feedback Program for Ferring Pharmaceuticals’ Osteoarthritis treatment, EUFLEXXA(TM)

WOBURN, Mass.--(BUSINESS WIRE)--InfoMedics, Inc., the patient feedback company, today announced interim results of a program the company is running with Ferring Pharmaceuticals, Inc. to measure patients' perceptions about their experiences with EUFLEXXA™, an intra-articular hyaluronic acid (IA-HA) for the relief of pain in knee osteoarthritis (OA).
MORE ON THIS TOPIC